Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis

@inproceedings{Pedersen2018EfficacyOA,
  title={Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis},
  author={Niels C Pedersen and Yunjeong Kim and Hongwei Liu and Anushka C. Galasiti Kankanamalage and Chrissy D Eckstrand and William C Groutas and Michael J Bannasch and Juliana M Meadows and Kyeong-Ok Chang},
  booktitle={Journal of feline medicine and surgery},
  year={2018}
}
Objectives The safety and efficacy of the 3C-like protease inhibitor GC376 was tested on a cohort of client-owned cats with various forms of feline infectious peritonitis (FIP). Methods Twenty cats from 3.3-82 months of age (mean 10.4 months) with various forms of FIP were accepted into a field trial. Fourteen cats presented with wet or dry-to-wet FIP and six cats presented with dry FIP. GC376 was administered subcutaneously every 12 h at a dose of 15 mg/kg. Cats with neurologic signs were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 22 times over the past 90 days. VIEW TWEETS